Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment-Reference-Cited by-同舟云学术

Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment

Published:1999-06 Issue:2 Volume:22 Page:168-170
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Drazen Jeffrey M.,Yandava Chandri N.,Dubé Louise,Szczerback Natalie,Hippensteel Richard,Pillari Antonino,Israel Elliot,Schork Nicholas,Silverman Eric S.,Katz David A.,Drajesk Jeffrey

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng0699_168.pdf

Reference25 articles.

1. Barnes, P.J. Drug therapy: inhaled glucocorticoids for asthma. N. Engl. J. Med. 332, 868–875 (1995).

2. Lemanske, R.F. & Busse, W.W. Asthma. JAMA 278, 1855–1873 (1997).

3. Busse, W.W. Leukotrienes and inflammation. Am. J. Respir. Crit. Care Med. 157, S210–S213 (1998).

4. Drazen, J.M., Israel, E. & Obyrne, P.M. Treatment of asthma with drugs modifying the leukotriene pathway. N. Engl. J. Med. 340, 197–206 (1999).

5. Obyrne, P.M., Israel, E. & Drazen, J.M. Antileukotrienes in the treatment of asthma. Ann. Intern. Med. 127, 472–480 (1997).

Cited by 487 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the structure–function relationship of missense mutations in the human TOP2A protein in ovarian cancer;Frontiers in Physics;2024-03-28

2. The IL-31/TRPV1 pathway mediates allergic asthma exacerbated by DINP dermal exposure in OVA-sensitized Balb/c mice;Science of The Total Environment;2024-02

3. Genetic and Epigenetic Factors in Risk and Susceptibility for Childhood Asthma;Allergies;2023-06-14

4. Association between Sex-Related ALOX5 Gene Polymorphisms and Lung Atopy Risk;Journal of Clinical Medicine;2023-04-08

5. Heterogeneity of Treatment Response to Asthma;Precision Approaches to Heterogeneity in Asthma;2023